Winner of SIX awards in 2021, NGX BodyFuel is The World’s First Genetically Personalised Meal-Shake (patent pending). After successfully launching and selling over 120,000 meals in the UK, NGX is raising capital to open the US market & accelerate the launch of new personalised nutrition products.
Everyone is genetically unique, with unique nutrition requirements. Current food supplements are often based on generic food guidelines that are unsuitable for achieving optimal levels of fitness & health. It used to be complex & expensive to determine an individual's unique nutrition targets. And it used to be a hassle to prepare fresh food every day to hit them – especially for busy people.
NGX BodyFuel is The World's First Genetically Personalised Meal-Shake, our patent-pending solution to this problem, based on a simple, at-home DNA Nutrition Test.
We have collected ~1m+ customer data points, sold 120,000+ meals of BodyFuel, developed proprietary gene-nutrition matching technology & for the last 6 months have achieved an average return on ad spend of £3.78 for every £1 spent.
We have secured partnerships with the likes of AMEX, Barclays, F45, Axa & Everyone Active. We have featured in the likes of Vogue, Men's Fitness, Women's Health & Dragon's Den – winning offers from Peter Jones & Touker Suleyman.
Our vision is to perfect individual nutrition, whoever you are, whatever your goal. We use our deep understanding of customer genetics & lifestyle choices to inform our R&D roadmap that aims to improve both customer health, & customer value to NGX.
We are raising with the aim of accelerating customer acquisition, launching new products & establishing a US market presence.
We started NGX to make personalised nutrition simple, convenient and affordable, so that everyone has the opportunity to become the best version of themselves. Our ambition is to become the most sought after personalised nutrition brand in the industry.
Jeremy Poland, CEO
9 years experience in management consulting, setting up brands and companies for a number of fortune 250 companies including J&J, Pfizer and Abbott.
Hugo Jones, COO
Serial entrepreneur experienced in leading startups such as Cult Events to million-pound revenue-generating companies.
Olga Hamilton (Part-time), VP of Nutrigenetic Science (FdSc, DipION, mBANT, CNHC Registered, PGDip)
10+ yrs experience as a registered nutritional therapist & thought leader in the emerging field of nutrigenetics – the science behind NGX.
Alex Blyth, Chairman
Extensive experience working in a cross-section of healthcare, pharma & business. Has brought over 50 novel products and brands to market. Including work for Novartis, GSK and J&J. Alex has built three companies and sold two.
Scientific: Prof. Roche (UCD), Prof. Muller (UEA), Prof. Karani (UoR)
|Date (document was filed at Companies House)||Type||Description (of the document filed at Companies House)||View / Download (PDF file, link opens in new window)|
|15 Sep 2022||AA01||Previous accounting period shortened from 28 February 2023 to 31 August 2022|
|25 Aug 2022||SH01||
Statement of capital following an allotment of shares on 18 July 2022
|19 Aug 2022||RESOLUTIONS||
|16 Aug 2022||SH01||
Statement of capital following an allotment of shares on 31 March 2022
|15 Aug 2022||RESOLUTIONS||
|16 May 2022||AA||Total exemption full accounts made up to 28 February 2022||
View PDF Total exemption full accounts made up to 28 February 2022 - link opens in a new window - 12 pages (12 pages)
|01 Feb 2022||CS01||Confirmation statement made on 31 January 2022 with updates|
|14 Sep 2021||AA||Total exemption full accounts made up to 28 February 2021||
View PDF Total exemption full accounts made up to 28 February 2021 - link opens in a new window - 11 pages (11 pages)
|25 Aug 2021||PSC01||Notification of Hugh Jones as a person with significant control on 18 August 2021|
|13 Apr 2021||CS01||Confirmation statement made on 19 February 2021 with updates|
|13 Apr 2021||RESOLUTIONS||
|13 Apr 2021||RESOLUTIONS||
|24 Feb 2021||PSC04||Change of details for Mr Alexander William Blyth as a person with significant control on 26 January 2021|
|24 Feb 2021||PSC04||Change of details for Mr Jeremy Duncan Poland as a person with significant control on 26 January 2021|
|24 Feb 2021||SH01||
Statement of capital following an allotment of shares on 26 January 2021
|24 Jan 2021||SH01||
Statement of capital following an allotment of shares on 22 December 2020
|24 Jan 2021||SH01||
Statement of capital following an allotment of shares on 17 December 2020
|01 Dec 2020||MA||Memorandum and Articles of Association|
|01 Dec 2020||RESOLUTIONS||
|22 Jul 2020||AA||Total exemption full accounts made up to 29 February 2020||
View PDF Total exemption full accounts made up to 29 February 2020 - link opens in a new window - 12 pages (12 pages)
|05 Mar 2020||CS01||Confirmation statement made on 19 February 2020 with updates|
|05 Mar 2020||SH01||
Statement of capital following an allotment of shares on 20 December 2019
|02 Jan 2020||PSC04||Change of details for Mr Alexander William Blyth as a person with significant control on 15 September 2019|
|17 Dec 2019||SH02||Sub-division of shares on 9 December 2019|
|16 Dec 2019||RESOLUTIONS||